explore -WSS

explore

author：hotspot 2025-09-29 22:48:39 - browse：373

Slayman with (left to right) Dr. Leo Riella, Medical Director of Kidney Transplantation, Dr. Nahel Elias, Interim Chief, Division of Transplant Surgery, his partner, Faren, and Dr. Tatsuo Kawai, Director, Legorreta Center for Clinical Transplant Tolerance. -- HEALTH coverage from STAT — Rick Slayman, holding hands with his partner, Faren, poses with members of his Massachusetts General Hospital medical team before being going home last month. Michelle Rose/Massachusetts General Hospital

Rick Slayman, the first man to receive a kidney transplant from a genetically engineered pig, has died, according to a statement from his family and Massachusetts General Hospital, where he underwent the historic operation in March.

“Our family is deeply saddened about the sudden passing of our beloved Rick but take great comfort knowing he inspired so many,” his family said in the statement released Saturday evening.

The hospital did not say how or when Slayman died. A spokesperson declined to provide further information, citing “privacy issues.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Pfizer plans to depart BIO

WSS

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

New England Journal of Medicine addresses racist history, slavery

STAT letters to the editor on burnt

Caregivers of transplant patients call for more support, training

In diabetes hearing, Sanders takes on a new foe: food makers

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

After affirmative action ruling, medical educators look to 'holistic review'

The SUPPORT Act is critical to fighting the opioid crisis

Jerome Adams on the need for new antivirals for Covid

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Apple is now the first public company to be valued at $3 trillion

FDA approves world's first CRISPR

Hollywood unions extend contract negotiations for actors

Pfizer plans to depart BIO

State Dept. review finds Biden bears some blame for Afghanistan failures

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

hotspot

The SUPPORT Act is critical to fighting the opioid crisis

The SUPPORT Act is critical to fighting the opioid crisis

What causes an itch? Researchers may have solved the mystery

New menopause drug shows promise in relief for hot flashes

New menopause drug shows promise in relief for hot flashes

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

entertainment

hotspot

leisure time

hotspot